Summary
- Current Price
- As of today, COLL price is $34.75, down -1.95% in the most recent trading session on
- Current Price All-Time High
- COLL price is currently -31.58% below its historical high of $50.79 set on
- Market Cap
- COLL current market cap is $1B, up +16.10% over the past 365 days
- PE Ratio
- COLL current PE ratio is 20.24
- Revenue
- COLL current annual revenue is $780.57M, up +23.62% year-over-year
- Next Earnings
- The next earnings release for COLL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Collegium Pharmaceutical, Inc. |
| Ticker | NASDAQ: COLL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | collegiumpharma.com |
| Employees | 357 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $34.75 | |
| Price, 1D Change | -1.95% | |
| $1B | ||
| - | ||
| 20.24 | ||
| 0.59 | ||
| $781M | ||
| Revenue, 1Y Change | +23.62% | |
| $1.73 | ||
| EPS, 1Y Change | -6.55% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.73 | ||
| EPS Estimate | N/A | $7.36 |
| EPS Est. Change | N/A | +324.31% |
| $780.57M | ||
| Revenue Estimate | N/A | $830.08M |
| Revenue Est. Change | N/A | +6.34% |
| Current Price | $34.75 | |
| Price Target | - | $56.00 |
| Price Tgt. Change | - | +61.15% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.18 | $1.86 | -69.96% | |
| $7.47 | $1.73 | -76.78% | |
| $7.36 | N/A | +324.31% | |
| $6.50 | N/A | +274.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $629.18M | $631.45M | +0.36% | |
| $781.48M | $780.57M | -0.12% | |
| $830.08M | N/A | +6.34% | |
| $777.26M | N/A | -0.42% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $34.75 | |
| $38.94 | ||
| SMA 200 vs Price | +12.07% | |
| $43.32 | ||
| SMA 50 vs Price | +24.65% | |
| 0.59 | ||
| $1.55 | ||
| 31.17 | ||
| 39.13% | ||
| 38.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $780.57M | ||
| $1.73 | ||
| $0.00 | ||
| 59.35% | ||
| $187.08M | ||
| 23.97% | ||
| $62.87M | ||
| 8.05% | ||
| $413.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 3.10 | ||
| 1.57 | ||
| 1.48 | ||
| - | ||
| 8 | ||
| 1.03 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 20.24 | ||
| 1.41 | ||
| 3.64 | ||
| 3.97 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $301.68M | ||
| $406.53M | ||
| $1.69B | ||
| $691.41M | ||
| $1.38B | ||
| $440.03M | ||
| $936.43M | ||
| $30.41M | ||
| $10.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $717.70M | ||
| $276.17M | ||
| $317.31M | ||
| $284.80M | ||
| $226.07M | ||
| $0.00 | ||
| $29.75M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $329.32M | ||
| -$63.53M | ||
| -$110.25M | ||
| $1.74M | ||
| $327.58M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Needham | → | |
| Barclays | ||
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with COLL
FAQ
What is the ticker symbol for Collegium Pharmaceutical, Inc.?
The ticker symbol for Collegium Pharmaceutical, Inc. is NASDAQ:COLL
Does Collegium Pharmaceutical, Inc. pay dividends?
No, Collegium Pharmaceutical, Inc. does not pay dividends
What sector is Collegium Pharmaceutical, Inc. in?
Collegium Pharmaceutical, Inc. is in the Healthcare sector
What industry is Collegium Pharmaceutical, Inc. in?
Collegium Pharmaceutical, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Collegium Pharmaceutical, Inc. based in?
Collegium Pharmaceutical, Inc. is headquartered in United States
When did Collegium Pharmaceutical, Inc. go public?
Collegium Pharmaceutical, Inc. initial public offering (IPO) was on May 7, 2015
Is Collegium Pharmaceutical, Inc. in the S&P 500?
No, Collegium Pharmaceutical, Inc. is not included in the S&P 500 index
Is Collegium Pharmaceutical, Inc. in the NASDAQ 100?
No, Collegium Pharmaceutical, Inc. is not included in the NASDAQ 100 index
Is Collegium Pharmaceutical, Inc. in the Dow Jones?
No, Collegium Pharmaceutical, Inc. is not included in the Dow Jones index
When was Collegium Pharmaceutical, Inc. last earnings report?
Collegium Pharmaceutical, Inc.'s most recent earnings report was on February 26, 2026
When does Collegium Pharmaceutical, Inc. report earnings?
The next expected earnings date for Collegium Pharmaceutical, Inc. is May 7, 2026
Data Sources & References
- COLL Official Website www.collegiumpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1267565/000162828026011992/0001628280-26-011992-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1267565/000162828026011992/0001628280-26-011992-index.htm
- COLL Profile on Yahoo Finance finance.yahoo.com/quote/COLL
- COLL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coll